|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/08 | |
| A61K 47/02 | |||
| A61K 31/473 | |||
| A61P 25/16 |
| (11) | Patento numeris | 3174526 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15766745.2 |
| Europos patento paraiškos padavimo data | 2015-07-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/001577 |
| Data | 2015-07-31 |
| (87) | Numeris | WO 2016/015875 |
| Data | 2016-02-04 |
| (30) | Numeris | Data | Šalis |
| 14002689 | 2014-08-01 | EP |
| (72) |
LEADER, Ian Philip, GB
|
| (73) |
Britannia Pharmaceuticals Limited,
200 Longwater Avenue Green Park, Reading, Berkshire RG2 6GP,
GB
|
| (54) | COMPOSITION CONTAINING APOMORPHINE AND A DIVALENT METAL CATION |
| COMPOSITION CONTAINING APOMORPHINE AND A DIVALENT METAL CATION |